These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16014148)

  • 1. Antibiotic-related renal failure and cystic fibrosis.
    Kennedy SE; Henry RL; Rosenberg AR
    J Paediatr Child Health; 2005 Jul; 41(7):382-3. PubMed ID: 16014148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Antibiotic renal failure and cystic fibrosis.
    Coulthard K; Smith C; Martin J
    J Paediatr Child Health; 2006; 42(1-2):72-3; author reply 73. PubMed ID: 16487396
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.
    O'Donnell EP; Scarsi KK; Scheetz MH; Postelnick MJ; Cullina J; Jain M
    Int J Antimicrob Agents; 2010 Jul; 36(1):94-5. PubMed ID: 20382508
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis.
    Kovesi TA; Swartz R; MacDonald N
    N Engl J Med; 1998 Jan; 338(1):65-6. PubMed ID: 9424574
    [No Abstract]   [Full Text] [Related]  

  • 7. Case-control study of acute renal failure in patients with cystic fibrosis in the UK.
    Smyth A; Lewis S; Bertenshaw C; Choonara I; McGaw J; Watson A
    Thorax; 2008 Jun; 63(6):532-5. PubMed ID: 18245146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled aminoglycosides in cystic fibrosis.
    Jew LL; Hart LL
    DICP; 1990; 24(7-8):711-2. PubMed ID: 2197811
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.
    Patatanian L
    Pediatr Infect Dis J; 2006 Mar; 25(3):276-8. PubMed ID: 16511399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal impairment following aminoglycoside therapy in cystic fibrosis.
    Tai A
    Thorax; 2008 Oct; 63(10):936; author reply 936-7. PubMed ID: 18820124
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S; Jones A; Brownlee K
    Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.
    Cabrera J; Arroyo V; Ballesta AM; Rimola A; Gual J; Elena M; Rodes J
    Gastroenterology; 1982 Jan; 82(1):97-105. PubMed ID: 6171479
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic dosing in extended dialysis.
    Kielstein JT; Burkhardt O
    Clin Infect Dis; 2009 Dec; 49(12):1963; author reply 1964. PubMed ID: 19929396
    [No Abstract]   [Full Text] [Related]  

  • 15. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report.
    Scott AI; Clarke BE; Healy H; D Emden M; Bell SC
    JOP; 2000 Nov; 1(4):208-10. PubMed ID: 11856863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successive courses of intensive therapy in cystic fibrosis (author's transl)].
    Feigelson J; Pecau Y; Gaultier C; Boule M; Høiby N
    Nouv Presse Med; 1981 Mar; 70(12):955-8. PubMed ID: 7208319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of bacterial infections in patients with kidney failure and hemodialysis].
    Yamasaku F
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1646-52. PubMed ID: 2079588
    [No Abstract]   [Full Text] [Related]  

  • 18. Fever associated with intravenous antibiotics in adults with cystic fibrosis.
    Mallon P; Murphy P; Elborn S
    Lancet; 1997 Dec; 350(9092):1676-7. PubMed ID: 9400516
    [No Abstract]   [Full Text] [Related]  

  • 19. Selected topics in novel methods of antibiotic delivery: aerosolized antibiotics and lipid preparations.
    Saiman L
    Adv Pediatr Infect Dis; 1997; 13():349-76. PubMed ID: 9544319
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.
    Ahya VN; Doyle AM; Mendez JD; Lipson DA; Christie JD; Blumberg EA; Pochettino A; Nelson L; Bloom RD; Kotloff RM
    J Heart Lung Transplant; 2005 Jul; 24(7):932-5. PubMed ID: 15982625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.